-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Operating Income (Loss) history and change rate from 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$5,652,689.000, a 58.4% decline year-over-year.
- Neuphoria Therapeutics Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$3,214,053.000, a 79.9% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Operating Income (Loss) for 2025 was -$1,129,091.000, a 93.7% increase from 2024.
- Neuphoria Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$17,892,376.000, a 18.6% increase from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)